Login to Your Account

IntraBiotics' Iseganan Fails To Reduce Mucositis In Phase III

By Brady Huggett

Tuesday, October 1, 2002
IntraBiotics Pharmaceuticals Inc. stopped development of iseganan for mucositis following a Phase III failure. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription